Fig. 1.

Change in serum alanine aminotransferase levels from baseline to 6 months after initiation of treatment with dapagliflozin or empagliflozin. a All participants, b participants on dapagliflozin, c participants on empagliflozin, d participants on insulin, e participants not on insulin)